| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.04. | Alnylam Presents Positive Results From KARDIA-2 Phase 2 Study Of Zilebesiran At ACC | 1.154 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - Alnylam Pharmaceuticals, Inc. (ALNY) presented KARDIA-2 Phase 2 study results of zilebesiran for the treatment of hypertension at the 2024 American College of... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| TESLA | 302 |
| NVIDIA | 265 |
| BAYER | 215 |
| NOVO NORDISK | 207 |
| LILIUM | 191 |
| BYD | 167 |
| EVOTEC | 164 |
| TUI | 149 |
| PALANTIR TECHNOLOGIES | 139 |
| D-WAVE QUANTUM | 128 |
| MICROSTRATEGY | 117 |
| VOLKSWAGEN | 116 |
| RWE | 88 |
| RHEINMETALL | 80 |
| NIO INC ADR | 79 |
| NEL | 78 |
| COMMERZBANK | 76 |
| DEUTSCHE TELEKOM | 75 |
| AMAZON | 72 |
| SUPER MICRO COMPUTER | 71 |
| AIXTRON SE | 70 |
| ATOS | 70 |
| XIAOMI | 70 |
| BASF | 69 |
| DEUTSCHE BANK | 68 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
